Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

19.27
Delayed Data
As of Oct 20
 +4.11 / +27.11%
Today’s Change
4.72
Today|||52-Week Range
19.34
+244.11%
Year-to-Date
Why UniQure (QURE) Stock is Skyrocketing Today
Oct 19 / Zacks.com - Paid Partner Content
uniQure (QURE) in Focus: Stock Moves 11.9% Higher
Oct 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close15.16
Today’s open16.75
Day’s range16.05 - 19.34
Volume9,934,411
Average volume (3 months)358,090
Market cap$388.5M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+18.45%
Earnings growth (this year)-3.24%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+140.14%
P/E ratio--
Price/Sales5.59
Price/Book6.02

Competitors

 Today’s
change
Today’s
% change
ONVOOrganovo Holdings In...+0.21+15.00%
--Wang On Group Ltd+0.00+75.00%
XBITXBiotech Inc-0.05-1.20%
KMDAKamada Ltd+0.10+2.04%
Data as of 4:00pm ET, 10/20/2017

Financials

Next reporting dateNovember 21, 2017
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$25.1M
Annual profit (last year)-$73.4M
Net profit margin-292.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Scott T. McMillan
Corporate headquarters
Amsterdam, Noord-holland

Forecasts